Ampio Pharmaceuticals, Inc. (AMPE)

Ampio Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Quarter	Current	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Sep 16, 2026	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Market Capitalization	0	2	3	4	4	3	14	38	107	129	326	329	331	294	169	105	66	92	71	55	62
Market Cap Growth (YoY)	6682.51%	-49.79%	-79.92%	-90.78%	-96.70%	-97.38%	-95.80%	-88.39%	-67.70%	-56.00%	92.75%	213.10%	401.73%	218.13%	137.09%	91.50%	5.51%	119.53%	31.66%	-71.13%	-78.35%
Enterprise Value	-	-4	-4	-6	-8	-13	-9	10	73	112	305	313	314	286	165	104	61	86	60	51	55
Last Close Price	0.18	2.05	3.64	4.66	4.66	4.50	18.15	50.40	141.00	171.00	498.00	501.00	507.00	477.00	287.10	191.07	124.50	174.90	150.33	116.34	168.60

Price Ratios

Fiscal Quarter	Current	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Sep 16, 2026	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
PE Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28.33	10.18
PB Ratio	0.06	0.51	0.51	0.54	0.45	0.29	0.99	1.90	4.80	4.75	18.85	16.15	19.71	16.80	15.75	16.55	33.06	14.36	17.22	4.93	-133.45
P/TBV Ratio	0.06	0.51	0.51	0.54	0.45	0.29	0.99	1.90	4.80	4.75	18.85	16.15	19.71	16.80	15.75	16.55	33.06	14.36	17.22	4.93	-

Financial Efficiency

Fiscal Quarter	Current	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Sep 16, 2026	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Debt / Equity Ratio	0.13	0.13	0.07	0.07	0.07	0.07	0.05	0.04	0.04	0.04	0.06	0.05	0.07	0.07	0.12	0.21	0.71	0.23	0.37	0.14	-3.52
Net Debt / Equity Ratio	-1.09	-1.09	-1.13	-1.00	-1.25	-1.01	-1.20	-1.12	-1.28	-1.23	-0.99	-1.02	-0.95	-0.94	-0.77	-0.62	-0.51	-0.97	-1.57	-1.01	7.50
Net Debt / EBITDA Ratio	0.39	0.39	0.63	0.48	0.59	0.62	0.65	0.94	1.26	1.72	1.21	1.53	1.28	1.12	0.46	0.20	0.05	0.36	0.51	1.19	0.39
Net Debt / FCF Ratio	0.43	0.43	0.57	0.41	0.53	0.56	0.81	1.21	1.92	2.37	1.28	1.70	1.10	1.11	0.50	0.21	0.06	0.40	0.50	0.97	0.31
Quick Ratio	2.12	2.12	3.07	3.35	3.89	10.64	4.41	4.58	5.32	6.79	7.63	6.74	10.44	9.70	5.00	2.09	0.54	1.80	3.38	5.50	3.31
Current Ratio	2.41	2.41	3.37	3.67	4.02	11.18	4.67	4.85	5.41	6.96	7.95	7.08	10.72	10.08	5.65	2.67	0.77	1.93	4.15	6.20	3.69
Return on Equity (ROE)	-113.96%	-113.96%	-91.53%	-104.89%	-97.43%	-83.62%	-130.71%	-86.80%	-97.59%	-76.23%	-110.49%	-113.88%	-153.24%	-132.70%	-165.48%	-185.05%	-1704.51%	-233.41%	-347.81%	52.72%	-
Return on Assets (ROA)	-61.57%	-61.57%	-47.22%	-49.25%	-51.00%	-48.61%	-81.42%	-58.04%	-54.40%	-41.67%	-50.15%	-47.65%	-55.73%	-53.67%	-75.65%	-79.92%	-127.81%	-82.84%	-55.36%	-41.22%	-47.17%
Return on Capital Employed (ROCE)	-283.30%	-283.30%	-186.10%	-215.30%	-220.20%	-164.40%	-180.40%	-113.10%	-87.00%	-61.00%	-75.90%	-62.60%	-67.90%	-75.20%	-140.00%	-224.60%	-501.90%	-191.20%	-102.90%	-57.80%	-93.20%

Yields

Fiscal Quarter	Current	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Sep 16, 2026	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Earnings Yield	-4152.32%	-506.09%	-320.10%	-397.28%	-417.14%	-480.88%	-148.58%	-46.01%	-17.84%	-13.19%	-4.75%	-4.63%	-4.35%	-5.40%	-7.28%	-15.38%	-19.72%	-14.74%	-15.55%	3.53%	9.82%
FCF Yield	-4119.61%	-502.10%	-383.81%	-452.89%	-525.30%	-621.90%	-150.02%	-48.53%	-13.96%	-10.96%	-4.11%	-3.71%	-4.38%	-5.03%	-9.86%	-17.75%	-26.58%	-16.66%	-18.31%	-21.10%	-18.18%
Buyback Yield / Dilution	-7.50%	-7.50%	-7.52%	-5.50%	-9.27%	-10.30%	-13.37%	-13.24%	-13.76%	-18.58%	-18.44%	-21.85%	-27.59%	-31.81%	-15.66%	-9.29%	-28.31%	-18.20%	-66.66%	-81.99%	-54.94%

Data Source: S&P Global Market Intelligence Last updated: Mar 27, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error